Figure 1

Plasma Adrenomedullin in all study groups. a. Control b. Diabetics without complications c. Diabetics with vasculopathy.
Plasma Adrenomedullin in all study groups. a. Control b. Diabetics without complications c. Diabetics with vasculopathy.